C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 235/38 (2006.01) A61K 31/195 (2006.01) A61K 31/196 (2006.01) A61K 31/235 (2006.01) A61K 31/245 (2006.01) A61K 31/365 (2006.01) A61K 31/44 (2006.01) A61K 31/695 (2006.01) C07D 213/30 (2006.01) C07D 307/88 (2006.01) C07F 7/10 (2006.01)
Patent
CA 2175854
Retinoid-like activity is exhibited by compounds of the formula Image wherein X is F, Cl, OH or CH3, Y is H or F, R1-R6 are each independently hydrogen or C1-C6 alkyl, n is an integer of 1 to 4 and R7 is hydrogen or a carboxyl-protecting group, and pharmaceutically acceptable salts thereof. The compounds of formula I selectively interact with the retinoic acid subtype RAR.gamma. and have been found to lack the liver toxicity associated with systemic administration of non-selective retinoids.
Smith Daniel
Swann R. Thomas
Tramposch Kenneth M.
Zusi Fred Christopher
Bristol-Myers Squibb Company
Cassan Maclean
LandOfFree
Rar(gamma)-specific retinobenzoic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rar(gamma)-specific retinobenzoic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rar(gamma)-specific retinobenzoic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1928149